Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sonoma Pharmaceuticals (SNOA) Return on Equity (2016 - 2025)

Sonoma Pharmaceuticals has reported Return on Equity over the past 15 years, most recently at 0.01% for Q4 2025.

  • For Q4 2025, Return on Equity changed 0.0% year-over-year to 0.01%; the TTM value through Dec 2025 reached 0.01%, changed 0.0%, while the annual FY2025 figure was 0.01%, 0.0% changed from the prior year.
  • Return on Equity for Q4 2025 was 0.01% at Sonoma Pharmaceuticals, down from 0.01% in the prior quarter.
  • Over five years, Return on Equity peaked at 0.0% in Q1 2021 and troughed at 0.01% in Q3 2023.
  • A 5-year average of 0.01% and a median of 0.01% in 2023 define the central range for Return on Equity.
  • Biggest five-year swings in Return on Equity: changed 0bps in 2021 and later fell -1bps in 2023.
  • Year by year, Return on Equity stood at 0.0% in 2021, then crashed by -20369bps to 0.01% in 2022, then tumbled by -34bps to 0.01% in 2023, then rose by 11bps to 0.01% in 2024, then fell by -27bps to 0.01% in 2025.
  • Business Quant data shows Return on Equity for SNOA at 0.01% in Q4 2025, 0.01% in Q3 2025, and 0.01% in Q2 2025.